Metformin Use and Breast Cancer Outcomes in Women with Type 2 Diabetes: A Policy Brief

AuthorMonirsadat Mirzadehen
AuthorMohsen Jafarien
AuthorAli Homaeien
AuthorEnsiyeh Bahadoranen
OrcidMonirsadat Mirzadeh [0000-0002-3781-6383]en
OrcidEnsiyeh Bahadoran [0000-0001-8299-1466]en
Issued Date2025-12-31en
AbstractBackground and Objectives: Breast cancer is the most common malignancy among women in Iran, and type 2 diabetes mellitus (T2DM) is a growing health challenge and a major comorbidity in these patients. Metformin, the first-line drug for diabetes management, has additional potential anticancer properties, in addition to its metabolic effects. Methods: This policy brief summarizes the evidence from a retrospective study conducted in Qazvin, Iran, on 104 patients with T2DM and breast cancer between 2019 and 2023, evaluating the association between metformin use and clinical and pathological outcomes in patients with T2DM and breast cancer. Results: The findings indicate that metformin use is associated with an earlier disease stage at presentation, lower lymph node involvement, and improved treatment response and prognosis. However, no significant associations were observed with hormone receptor status, recurrence, or metastasis. Conclusions: These findings suggest that metformin may be repurposed to improve the prognosis of patients with T2DM and breast cancer. It is recommended that health policymakers support prospective cohort studies and develop clinical guidelines to consider metformin as part of the treatment protocol for these patients.en
DOIhttps://doi.org/10.69107/jid-169792en
URIhttps://brieflands.com/journals/jid/articles/169792en
KeywordBreast Canceren
KeywordDiabetes Mellitus Type 2en
KeywordMetforminen
KeywordPolicy Briefen
PublisherBrieflandsen
TitleMetformin Use and Breast Cancer Outcomes in Women with Type 2 Diabetes: A Policy Briefen
TypeBrief Reporten

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
jid-29-4-169792-publish-pdf.pdf
Size:
92.26 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF